Abstract
Telemedicine for cancer patients during COVID-19 pandemic: between threats and opportunities.
Highlights
SARS-CoV-2 or COVID-19 is a novel strain of coronavirus
Governments are imposing confinement rules, limiting all kinds of transportation. This has led to the reliance on telecommunications, from online education and remote working from home, to telemedicine
Many medical societies and physicians are adopting this option as the safest, both for the patient and the medical staff [3]. This new perspective has led us to wonder whether telemedicine is a threat to oncology patient care or an opportunity that could revolutionize our clinical practice
Summary
SARS-CoV-2 or COVID-19 is a novel strain of coronavirus. To this date (the 7th of April 2020), around 1.4 million individuals have been affected by the disease worldwide, with nearly 80,000 deaths, according to the WHO [1]. This new perspective has led us to wonder whether telemedicine is a threat to oncology patient care or an opportunity that could revolutionize our clinical practice. Using the same sociological approach, patients may refuse to receive care from a distance, while others may insist on this technology when it may be necessary for them to go to the clinic.
Sign-in/Register to view highlights & summary Sign-in/Register to access full text options 
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
